INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
116 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

Page 110 of 508
← PrevNext →
8
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL
$6,100
100 sh
Sep 15, 2026
Sep 17, 2026
traded Sep 15, 2026
+2d
SEC Form 4

Evidence

8
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$685K
18.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
1,100 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
586 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
1,214 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$90K
510 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$223K
1,308 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
700 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

6
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$10K
1,000 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$333K
60.0K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

4
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$382K
75.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$337K
60.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$341K
60.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
200 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
300 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

3
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
200 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
3,328 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
3,329 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

1
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$113K
6,657 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

55
BM
Beaulier Jonathan MeadChief Revenue Officer
SNOWSnowflake Inc.
Open-market sale
SELL$4.13M
12.3K sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

51
ZM
Zhuang MingzheDirector
IBEXIBEX Ltd
Open-market sale
SELL$221K
5,522 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

50
TA
Trofimuk-O'Connor Christina AliceChief Legal Officer
IBEXIBEX Ltd
Open-market sale
SELL$302K
7,500 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

48
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Open-market sale
SELL$256K
768 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

47
TA
Tiran AssafEVP Cross Suez & Atlantic BU
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$93K
3,156 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

44
TA
Tiran AssafEVP Cross Suez & Atlantic BU
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$46K
1,571 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

42
CK
Casteel Julie KChief Sales/Marketing Officer
IBEXIBEX Ltd
Open-market sale
SELL$706K
17.5K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

39
TA
Trofimuk-O'Connor Christina AliceChief Legal Officer
IBEXIBEX Ltd
Open-market sale
SELL$93K
2,376 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

39
BD
Ballou-Aares DaniellaDirector
IBEXIBEX Ltd
Open-market sale
SELL$60K
1,500 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

39
IJ
Inson Paul JosephChief People Officer
IBEXIBEX Ltd
Open-market sale
SELL$100K
2,500 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

36
WH
Wang HaichenDirector, Chief Financial Officer
BULLWebull Corp
Open-market sale
SELL$494K
55.0K sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence

35
RV
Raghunathan VivekSVP, Engineering
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$1.23M
3,876 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC Form 4

Evidence

33
CZ
Chen ZhiwuDirector
GCTGigaCloud Technology Inc
Open-market sale
SELL$79K
1,500 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence

33
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$1.42M
300.0K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

32
RM
Rutledge Joseph MVP, CAO
NDSNNORDSON CORP
Open-market sale
SELL$212K
684 sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC Form 4

Evidence

31
AO
Atay OguzhanDirector, Chairman and CEO
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$319K
3,143 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence

31
BW
Bode WilliamChief Operating Officer
PLNTPlanet Fitness, Inc.
Open-market sale
SELL$359K
7,000 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence

30
FC
Folena ChrisChief Accounting Officer
OFRMOnce Upon a Farm, PBC
Open-market sale
SELL$11K
662 sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC Form 4

Evidence